Organogenesis Holdings Inc (NASDAQ: ORGO) open the trading on Thursday, with a bit cautious approach as it glided -9.59% to $4.01, before settling in for the price of $4.43 at the close. Taking a more long-term approach, ORGO posted a 52-week range of $2.16-$4.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 19.04% over the last 5 years. Nevertheless, stock’s Earnings Per Share (EPS) this year is -150.90%. This publicly-traded company’s shares outstanding now amounts to $131.32 million, simultaneously with a float of $77.76 million. The organization now has a market capitalization sitting at $530.97 million. At the time of writing, stock’s 50-day Moving Average stood at $2.99, while the 200-day Moving Average is $2.89.
Organogenesis Holdings Inc (ORGO) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. Organogenesis Holdings Inc’s current insider ownership accounts for 41.34%, in contrast to 47.30% institutional ownership. According to the most recent insider trade that took place on Jan 09 ’24, this organization’s 10% Owner sold 197,921 shares at the rate of 4.37, making the entire transaction reach 863,985 in total value, affecting insider ownership by 59,025,106. Preceding that transaction, on Jan 10 ’24, Company’s 10% Owner sold 17,972 for 4.28, making the whole transaction’s value amount to 76,875. This particular insider is now the holder of 59,007,134 in total.
Organogenesis Holdings Inc (ORGO) Earnings and Revenue Records
Organogenesis Holdings Inc’s EPS decrease for this current 12-month fiscal period is -150.90% and is forecasted to reach 0.03 in the upcoming year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Let’s observe the current performance indicators for Organogenesis Holdings Inc (ORGO). It’s Quick Ratio in the last reported quarter now stands at 2.74. The Stock has managed to achieve an average true range (ATR) of 0.27. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.17. Similarly, its price to free cash flow for trailing twelve months is now 136.49.
In the same vein, ORGO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.06, a figure that is expected to reach -0.01 in the next quarter, and analysts are predicting that it will be 0.03 at the market close of one year from today.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
[Organogenesis Holdings Inc, ORGO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 80.57% While, its Average True Range was 0.33.
Raw Stochastic average of Organogenesis Holdings Inc (ORGO) in the period of the previous 100 days is set at 75.33%, which indicates a major rise in contrast to 68.96% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 120.66% that was higher than 71.97% volatility it exhibited in the past 100-days period.
